Pharmacological inhibition of SLC25A1 by 1,2,3-benzene-tricarboxylic acid (BTA) treatment enhanced radiosensitivity of lung cancer cells and delayed repair of radiation-induced DNA damage [6]. This evidence concerns the gene SLC25A1 and lung cancer.